Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Lisata Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 34 | 36 | +2 |
| Shares | 7.71M | 8.71M | +995.6K (+12.9%) |
| Value | $9.41M | $7.33M | −$2.08M (−22.1%) |
New holders (8)
Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 237,400 | $200.0K | 0.00% |
| Anson Funds Management LP | 169,432 | $143.0K | 0.02% |
| Two Sigma Investments, LP | 160,145 | $135.0K | 0.00% |
| Virtu Financial LLC | 160,266 | $135.0K | 0.01% |
| Alterna Wealth Management, Inc | 73,000 | $61.0K | 0.05% |
| Jane Street Group, LLC | 21,885 | $18.0K | 0.00% |
| Index Fund Advisors, Inc. | 10,434 | $9.00K | 0.00% |
| Spire Wealth Management | 2,278 | $2.00K | 0.00% |
Sold out (6)
Institutions that held Lisata Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 74,198 | $91.0K |
| Two Sigma Securities, LLC | 26,933 | $33.0K |
| Wolverine Trading, LLC | 26,031 | $30.0K |
| Qube Research & Technologies Ltd | 21,043 | $26.0K |
| Game Plan Financial Advisors, LLC | 17,000 | $21.0K |
| Brewin Dolphin Ltd | 10 | $12 |